The Tri-Institutional MD-PhD Program is a joint undertaking of Weill Cornell Medical College (WCMC), The Rockefeller University (RU), and the Sloan-Kettering Institute for Cancer Research (SKI). Its mission is to train biomedical investigators who: on the one hand, have advanced understanding of biomedical science and a mastery of contemporary research skills, which will allow them to undertake fundamental studies to elucidate basic biological processes pertaining to human disease;and, on the other hand, are well grounded in human biology, pathobiology and clinical medicine, which will equip them to transfer advances in basic research to the understanding, prevention, and treatment of human disease. The three institutions operate three graduate schools: Weill Cornell Graduate School of Medical Sciences (WCGS), a joint undertaking between WCMC and SKI;the David Rockefeller Graduate School at RU;and the Gerstner Graduate School of Biomedical Sciences (GSK) at SKI. The Tri-Institutional MD-PhD Program was formed in 1991, when two independent MD-PhD Programs, the WCMC-RU Program and the WCMC-WCGS Program, were joined to form the present program. GSK became part of the Program in 2009. MSTP trainees complete all the requirements for the MD degree at WMC. They will get their PhD training in research laboratories in the three research institutions and receive their PhD degree from GSK, RU or WCGS. Accepted trainees arrive in early July before the start of medical school. During the first two years in the Program they complete their medical school course, take two graduate level courses designed for MD-PhD students, and complete three research rotations (in three different laboratories) before they settle into their thesis laboratory. When te students choose a research laboratory they enroll in the graduate school with which their thesis mentor is associated. The graduate course and thesis requirements are comparable for all MD-PhD students, irrespective of the graduate school in which they are matriculated-and the students can cross register and take courses for credit in any of the graduate schools. At the end of their research training, after they have defended their thesis, the students return to complete their clinical training at WMC. The present application requests funds to continue MD-PhD training at the three institutions beyond Year 40 (the predecessor WCMC-RU Program was formed in 1972;it received NIH funding in 1974). In its current iteration, the Program brings together faculty in more than 270 independent research laboratories. 317 MD- PhDs have graduated from the Tri-Institutional MD-PhD Program and its predecessors;currently there are 108 students in the Program. The current trainees come from 54 undergraduate schools. Their average GPA is 3.75, the combined MCAT score is 35.1. 94% of the graduates pursue post-graduate clinical training;of the 231 graduates who have completed their training, 202 (87%) have appointments in medical schools, research institutes or biotech/pharma.
The increasing pace at which biomedical research advances increases, means that there is a greater need than ever for physicians who have received rigorous training and thus are able to work at important problems at the intersection between clinical medicine and laboratory science and thereby contribute toward improving health and enhancing the quality of life by reducing disability and death from disease. The goal of the Weill Cornell/Rockefeller/Sloan- Kettering Tri-Institutional Medical Scientist Training Program is to identify, train and mentor a diverse group of outstanding men and women to become the future leaders in biomedical research and patient care as scientists, educators and clinicians.
|Dubrovsky, Leonid; Brea, Elliott Joseph; Pankov, Dmitry et al. (2016) Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity. Oncoimmunology 5:e1211221|
|Comer, John D; Cui, Xiaoyan; Eisen, Carolyn Sharyn et al. (2016) Myofibroblastoma of the male breast: a rare entity with radiologic-pathologic correlation. Clin Imaging 42:109-112|
|Kinet, Maxime J; Malin, Jennifer A; Abraham, Mary C et al. (2016) HSF-1 activates the ubiquitin proteasome system to promote non-apoptotic developmental cell death in C. elegans. Elife 5:|
|Alabi, Rolake O; Glomski, Krzysztof; Haxaire, Coline et al. (2016) ADAM10-Dependent Signaling Through Notch1 and Notch4 Controls Development of Organ-Specific Vascular Beds. Circ Res 119:519-31|
|Vazirani, Reema P; Verma, Akanksha; Sadacca, L Amanda et al. (2016) Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance. Diabetes 65:1577-89|
|Alidori, Simone; Bowman, Robert L; Yarilin, Dmitry et al. (2016) Deconvoluting hepatic processing of carbon nanotubes. Nat Commun 7:12343|
|Taggart, James; Ho, Tzu-Chieh; Amin, Elianna et al. (2016) MSI2 is required for maintaining activated myelodysplastic syndrome stem cells. Nat Commun 7:10739|
|Stamatiades, Efstathios G; Tremblay, Marie-Eve; Bohm, Mathieu et al. (2016) Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell 166:991-1003|
|Gitlin, Alexander D; von Boehmer, Lotta; Gazumyan, Anna et al. (2016) Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory. Immunity 44:769-81|
|Chang, Aaron Y; Gejman, Ron S; Brea, Elliott J et al. (2016) Opportunities and challenges for TCR mimic antibodies in cancer therapy. Expert Opin Biol Ther 16:979-87|
Showing the most recent 10 out of 393 publications